I
t is a great honor to pay homage to Michaela Modan at the Council on Epidemiology of the American Diabetes Association. First, it is an honor to speak at all, in that I am certainly not a "boardcertified" epidemiologist. Second, 1 am honored to have been a close friend of as wonderful an individual as Mickey Modan. I should say that I did not know Mickey for an extended period, and really came to meet her at the IDF meeting in Sydney some 5 years ago. After that meeting, she was kind enough to invite me and my family to Israel for the first time. During that visit to Israel, Mickey and I spent a great deal of time together, and it was there that our friendship really developed. I was lucky to have been able to interact with her scientifically and socially. Little did I know at that time how precious the moments really were.
Mickey had an interesting background. She was a Sabra, a first-generation Israeli, born of Polish parents. Her initial training was in bacteriology. Later, she moved into biostatistics. It is clear that her biological training was of great importance, because her particular strength was having a broad view of community health, integrating populationbased information with her understanding of biological mechanisms.
In 1959 Mickey came to the U.S., along with her husband Baruch, for training at Mount Sinai Hospital in New York, and later Johns Hopkins. Returning to Israel, she took a position as research methodologist at the Chlam Sheba Medical Center at Tel Hashomer, near Tel Aviv. In 1979 she was elevated to the position of Head of the Biometry Unit. Upon completion of her PhD, she joined the faculty and was made Professor of Epidemiology. Michaela was a highly productive and respected scientist, and produced over 150 original publications and numerous book chapters and delivered many lectures at prestigious international conferences. Thus, on a professional level alone, Michaela will be sorely missed.
It is not possible to comment on all aspects of such a prolific career. However, many of us remember the recent contributions of Michaela to the relationship between plasma insulin, hypertension, and cardiovascular risk factors. She produced one of the most influential studies of hyperinsulinemia and hypertension, published in the journal of Clinical per, entitled "Hyperinsulinemia, a link between hypertension, obesity, and glucose intolerance," has had a major impact on the now common view that insulin per se, or insulin resistance, is an important and possibly causative risk factor in the cluster of symptoms referred to as syndrome X. Her work contributed substantially to the design of population-based studies, including the Insulin Resistance and Atherosclerosis study ongoing at four centers in the U.S. Her work has affected me personally, because the potential importance of insulin resistance in a chronic disease cluster has led to the use of the minimal model as a method for assessment of insulin resistance in moderatesized populations. Thus today we celebrate a person who was clearly responsible in a major way for moving beyond insulin resistance as a risk factor for type II diabetes, to comprehension of resistance's putative role in the etiology of many chronic illnesses including hypertension and atherosclerosis.
Mickey had many wonderful qualities. Working with her closely revealed those which contributed to her professional success. She was a very persistent individual, with fantastic insights. Once a concept entered her brain, it stayed there a long time. Once she decided to employ a certain technology, she would explore every aspect of it until she had a deep understanding of its advantages and deficiencies. She had a very rare ability to look beyond her own expertise, and bring into her research biological concepts that might have initially been foreign to her. She was not afraid to examine the relation between insulin resistance and blood pressure; this required a deeper understanding of insulin resistance. Hyperinsulinemia led her to focus on the sympathetic nervous system. I was impressed that an epidemiologist was comfortable regarding the "state" of the sympathetic nervous system as a physiological variable that can be considered in a population study. Thus, it is clear that in Michaela Modan we had a scientist who DIABETES CARE, VOLUME 17, NUMBER 7, JULY 1994
Tribute was broad enough to bring disparate biological concepts to epidemiological studies, but who was willing to plunge with remarkable depth into the concepts and methods the data forced her to deal with.
Finally, it is important to comment on Michaela's very human qualities. She was an extremely devoted mother, raising three daughters, and constantly concerned with their welfare and happiness. She was a proud and loving grandmother. She was a great patriot, who recognized with stark clarity the greatness and the weaknesses of the state of Israel.
Most of all, Michaela Modan was a great feminist. Despite her family, and despite the prominence of her husband, she decided, once her children were out on their own, to strike out in an independent direction. It was in middle age that Mickey really came into her own, and established her international reputation for the insulin/hypertension relationship. It was not easy for her to do this. She not only had to content with the usual skepticism of the scientific community, and the brusqueness of the Israeli scene, but also she had to make her local environment accept her new status. She continued her career with strength and courage, even as her disease was getting worse. She discussed her disease dispassionately with me, and even near the end made plans with her husband, Baruch, to continue her studies. This was among her last efforts in the hospital.
It has been my honor to know and love Michaela Modan. It has been the honor of the American Diabetes Association to have such a loving and talented colleague. She will be missed, but we will never forget her contributions and her wonderful and giving personality.
